Amniotic Membrane Market Size, Share & Industry Analysis, By Product Type (Cryopreserved Amniotic Membranes and Lyophilized (Dehydrated) Amniotic Membranes), By Application (Ophthalmology, Wound Care, Orthopedics & Sports Medicine, Dental Applications, Plastic & Reconstructive Surgery, and Others), By End-user (Hospitals & ASCs, Specialty Clinics, and Research & Academic Institutes), and Regional Forecast, 2026-2034

The global amniotic membrane market size was valued at USD 1.29 billion in 2025. The market is projected to grow from USD 1.38 billion in 2026 to USD 2.56 billion by 2034, exhibiting a CAGR of 8.0% during the forecast period.

Amniotic membranes are derived from the inner layer of the placenta and are processed into grafts that help protect wounds, reduce inflammation, and promote natural healing. These products are widely used in chronic wound treatment, ophthalmology, and certain surgical procedures. Market growth is attributed to the increasing emphasis on biologic tissues for wound healing, the rising number of chronic wounds such as diabetic foot ulcers and venous leg ulcers, and the rising demand for advanced treatment methods. In addition, hospitals and wound care clinics are adopting biologic materials because they can accelerate healing and improve patient outcomes compared with conventional dressings. In addition, increased awareness among physicians and improvements in tissue-processing technologies are supporting wider adoption of these products.

• For instance, in May 2025, MiMedx Group, Inc. announced the publication of health economics data related to the use of its placental tissue products in Mohs micrographic surgery, supporting the clinical and economic value of these regenerative therapies.

Furthermore, many key industry players, such as MiMedx Group, Inc., Organogenesis Holdings Inc., Integra LifeSciences, TissueTech, Inc., and Amnio Technology, LLC, operating in the market, are focusing on developing various innovative technologies to offer better products with improved accuracy and efficiency.

AMNIOTIC MEMBRANE MARKET TRENDS

Increasing Use of Biologic Regenerative Products is One of the Important Trends Observed in the Market

A key trend in the amniotic membrane market is the growing adoption of biologic regenerative materials in clinical treatment. Healthcare providers are increasingly shifting from traditional wound dressings toward advanced regenerative therapies that support faster tissue repair. In addition, amniotic membrane grafts contain natural growth factors and structural proteins that help promote healing and reduce inflammation. In addition, improvements in preservation technologies have made these grafts easier to store and apply in clinical settings, further encouraging their adoption across hospitals and specialty clinics.

• For instance, in February 2026, Royal Biologics announced a strategic partnership with Jellagen Ltd. to boost the adoption of regenerative medicine products.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Prevalence of Chronic Wounds to Accelerate the Market Development

One of the key drivers of the global amniotic membrane market growth is the increasing prevalence of chronic wounds, particularly diabetic foot ulcers and venous leg ulcers. Moreover, the global rise in diabetes and aging populations has led to a growing number of patients requiring long-term wound care treatment. In addition, traditional wound dressings often struggle to heal complex wounds effectively, leading clinicians to adopt advanced biologic materials that support tissue regeneration.

MARKET RESTRAINTS

High Treatment Costs to Deter Market Growth

Despite their clinical benefits, the high cost of amniotic membrane products remains a key restraint for the market. Advanced biologic grafts require specialized processing, preservation, and regulatory compliance, which increases manufacturing costs. As a result, these products can be significantly more expensive than traditional wound care materials. In many healthcare systems, reimbursement coverage for biologic grafts is still evolving, which may limit their adoption in cost-sensitive settings.

MARKET OPPORTUNITIES

Expansion of Advanced Wound Care Centers to Offer Lucrative Market Growth Opportunities

A major opportunity for the market lies in the rapid expansion of specialized wound care centers and outpatient treatment facilities. Many healthcare systems are investing in dedicated wound care clinics to manage the growing burden of chronic wounds. These facilities often adopt advanced biologic therapies earlier than general hospitals, as their focus is on improving wound-healing outcomes. As more patients seek treatment at specialized wound care centers, demand for regenerative graft materials, such as amniotic membranes, is expected to increase.

MARKET CHALLENGES

Regulatory and Compliance Requirements Pose a Critical Challenge to Market Growth

One of the major challenges in the amniotic membrane market is navigating complex regulatory and compliance requirements, as these products are derived from human tissue, manufacturers must comply with strict regulations governing donor screening, tissue processing, and product safety. Regulatory authorities require extensive documentation and quality controls to ensure that these biologic materials meet safety standards. Compliance with these regulations can increase operational costs and extend product approval timelines. Companies entering the market must invest heavily in regulatory expertise and manufacturing infrastructure.

Segmentation Analysis

By Product Type

Substantial Bio-Compatibility of Cryopreserved Amniotic Membranes to Boost Segmental Growth

Based on product type, the market is divided into cryopreserved and lyophilized (dehydrated) amniotic membranes.

The cryopreserved amniotic membrane segment is anticipated to account for the largest amniotic membrane market share. The segment's growth is attributed to the substantial biocompatibility of cryopreserved amniotic membranes and new product launches. Moreover, cryopreservation helps preserve important proteins and growth factors that support tissue repair and healing. These products are widely used in ophthalmology and wound care applications where maintaining the membrane's natural structure is beneficial.

The lyophilized (dehydrated) amniotic membrane segment is anticipated to grow at a CAGR of 7.3% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Application

Higher Prevalence of Chronic Wounds to Accelerate Wound Care Segment's Growth

Based on application, the market is segmented into ophthalmology, wound care, orthopedics & sports medicine, dental applications, plastic & reconstructive surgery, and others.

In 2025, the wound care segment dominated the global market. Chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers require advanced treatment approaches when conventional dressings fail to promote healing. Amniotic membrane grafts help create a protective barrier and support tissue regeneration, making them highly suitable for treating complex wounds. The increasing prevalence of diabetes and aging populations worldwide has significantly increased the number of patients suffering from chronic wounds. As healthcare providers focus on reducing wound healing time and improving patient outcomes, the adoption of amniotic membrane products in wound care continues to expand.

Additionally, the orthopedics & sports medicine segment is expected to grow at a 9.0% CAGR over the forecast period.

By End-User

Higher Volume of Surgical Procedures and Advanced Wound Care Treatments to Accelerate Hospitals & ASCs Segment Growth

Based on end-user, the market is segmented into hospitals & ASCs, specialty clinics, and research & academic institutes.

The hospitals dominated the global market. Hospitals and ambulatory surgical centers (ASCs) account for the largest share of the amniotic membrane market. These facilities handle a large volume of surgical procedures and advanced wound care treatments, making them major users of biologic graft materials. Hospitals often have specialized departments for wound care, ophthalmology, and reconstructive surgery where amniotic membrane products are commonly used. In addition, hospitals typically have the infrastructure and trained staff to safely store and apply biologic grafts. Furthermore, the segment is set to hold 70.4% share in 2026.

In addition, the specialty clinics segment is projected to grow at a CAGR of 8.4% during the study period.

Amniotic Membrane Market Regional Outlook

By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024 with USD 0.50 billion and maintained its leading position in 2025 with USD 0.54 billion. The market in North America is expected to grow due to greater emphasis on regenerative medicines, expanding surgical applications of amniotic membranes, and a supportive regulatory environment.

U.S Amniotic Membrane Market

Given North America's strong contribution and the U.S. dominance in the region, the U.S. market can be estimated at around USD 0.49 billion in 2026, accounting for roughly 35.8% of global sales.

Europe

Europe is projected to grow at 7.5% over the coming years and reach a valuation of USD 0.39 billion by 2026. The region is expected to see significant market growth driven by the rising prevalence of chronic wounds and technological advancements.

U.K Amniotic Membrane Market

The U.K. market in 2026 is estimated at around USD 0.07 billion, representing roughly 4.7% of global revenues.

Germany Amniotic Membrane Market

Germany's market is projected to reach approximately USD 0.09 billion in 2026, equivalent to around 6.5% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 0.31 billion in 2026 and secure the position of the third-largest region in the market. Increasing awareness of regenerative medicines in the Asia Pacific is projected to positively impact regional market growth.

Japan Amniotic Membrane Market

The Japanese market in 2026 is estimated at around USD 0.05 billion, accounting for roughly 3.9% of global revenues.

China Amniotic Membrane Market

China's market is projected to be among the largest worldwide, with 2026 revenues estimated at around USD 0.10 billion, roughly 7.5% of global sales.

India Amniotic Membrane Market

The Indian market in 2026 is estimated at around USD 0.07 billion, accounting for roughly 5.0% of global revenues.

Latin America and the Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 0.07 billion in 2026. In the Middle East & Africa, the GCC is set to reach USD 0.01 billion in 2026. The strengthening of healthcare infrastructure in Latin America and the Middle East & Africa, along with the region's substantial prevalence of chronic wounds, is driving regional growth.

South Africa Amniotic Membrane Market

The South African market is projected to reach approximately USD 0.01 billion in 2026, accounting for roughly 0.38% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Rising Emphasis on Regenerative Medicines by Key Industry Players to Boost Market Progress

The global amniotic membrane market has a semi-consolidated structure, with prominent players including MiMedx Group, Inc., Organogenesis Holdings Inc., Integra LifeSciences, TissueTech, Inc., and Amnio Technology, LLC. Numerous strategic initiatives, including product approvals and distribution collaborations, drive these companies' significant global market share.

• For instance, in March 2026, MIMEDX announced the expansion of its product portfolio by launching AMNIOFIX thyroid shields, an amniotic product designed for endocrine procedures.

Other notable players in the global market include Surgenex, VIVEX Biologics, Applied Biologics, and Katena Products. These companies are expected to prioritize new product launches and collaborations to increase their global market share during the forecast period.

LIST OF KEY AMNIOTIC MEMBRANE COMPANIES PROFILED

• MiMedx Group, Inc. (U.S.)
• Organogenesis Holdings Inc. (U.S.)
• Integra LifeSciences (U.S.)
• TissueTech, Inc. (U.S.)
• Amnio Technology, LLC (U.S.)
• Surgenex (U.S.)
• VIVEX Biologics (U.S.)
• Applied Biologics (U.S.)
• Corza Ophthalmology (U.S.)
• NuVision Biotherapies (U.K.)

KEY INDUSTRY DEVELOPMENTS

• December 2025: BioStem Technologies, Inc. announced the launch of its new product, American Amniotic, at the Wound Care Conference in Phoenix, Arizona. The product is specifically designed for acute or chronic wounds.
• May 2025: A group of researchers at the Francis Crick Institute announced the development of a new stem model of the human amniotic sac.
• October 2023: BioTissue reported clinical study results demonstrating improved outcomes in dry eye disease patients treated with its Prokera Slim amniotic membrane therapy.
• November 2022: MiMedx Group, Inc. reported the launch of AXIOFILL and AMNIOEFFECT, new placental tissue-based products designed for surgical recovery applications.
• January 2022: Akorn Eye Care announced the introduction of amniotic membrane for ocular repair. The newly introduced product is called AcellFX.

REPORT COVERAGE

The global amniotic membrane market analysis includes a comprehensive study of the market size & forecast across all market segments covered in the report. It includes details on the market dynamics and trends expected to drive the market over the forecast period. It provides information on key aspects, including technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, key industry developments, and investments by key regions. The global market research report also provides a detailed competitive landscape, including market share and profiles of key players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation